Ayala Pharmaceuticals Inc. [AYLA] stock Initiated by Maxim Group analyst, price target now $22


Ayala Pharmaceuticals Inc. [NASDAQ: AYLA] surged by $0.28 during the normal trading session on Friday and reaching a high of $2.13 during the day while it closed the day at $1.71. The company report on July 29, 2022 that Thinking about buying stock in Ayala Pharmaceuticals, Kaltura, Plug Power, Ford Motor, or FuelCell Energy?.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


InvestorsObserver issues critical PriceWatch Alerts for AYLA, KLTR, PLUG, F, and FCEL.

To see how InvestorsObserver’s proprietary scoring system rates these stocks, view the InvestorsObserver’s PriceWatch Alert by selecting the corresponding link.

Ayala Pharmaceuticals Inc. stock has also gained 108.41% of its value over the past 7 days. However, AYLA stock has declined by -33.46% in the 3 months of the year. Over the past six months meanwhile, it has lost -69.02% and lost -79.91% year-on date.

The market cap for AYLA stock reached $20.71 million, with 15.30 million shares outstanding and 9.68 million shares in the current float. Compared to the average trading volume of 1.87M shares, AYLA reached a trading volume of 23112513 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Ayala Pharmaceuticals Inc. [AYLA]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AYLA shares is $13.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AYLA stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Maxim Group have made an estimate for Ayala Pharmaceuticals Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 20, 2021. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on December 20, 2021, representing the official price target for Ayala Pharmaceuticals Inc. stock. Previously, the target price had yet another raise from $12 to $17, while Jefferies kept a Buy rating on AYLA stock.

The Average True Range (ATR) for Ayala Pharmaceuticals Inc. is set at 0.28, with the Price to Sales ratio for AYLA stock in the period of the last 12 months amounting to 6.90. The Price to Book ratio for the last quarter was 1.06, with the Price to Cash per share for the same quarter was set at 2.24.

AYLA stock trade performance evaluation

Ayala Pharmaceuticals Inc. [AYLA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 108.41. With this latest performance, AYLA shares gained by 72.73% in over the last four-week period, additionally sinking by -69.02% over the last 6 months – not to mention a drop of -86.04% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AYLA stock in for the last two-week period is set at 61.91, with the RSI for the last a single of trading hit 67.57, and the three-weeks RSI is set at 56.47 for Ayala Pharmaceuticals Inc. [AYLA]. The present Moving Average for the last 50 days of trading for this stock 1.4047, while it was recorded at 1.4340 for the last single week of trading, and 5.1807 for the last 200 days.

Ayala Pharmaceuticals Inc. [AYLA]: An insightful look at the core fundamentals

Ayala Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.50 and a Current Ratio set at 5.50.

Ayala Pharmaceuticals Inc. [AYLA]: Insider Ownership positions

There are presently around $8 million, or 54.90% of AYLA stock, in the hands of institutional investors. The top three institutional holders of AYLA stocks are: HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. with ownership of 2,153,273, which is approximately -0.027% of the company’s market cap and around 2.80% of the total institutional ownership; IKARIAN CAPITAL, LLC, holding 708,383 shares of the stock with an approximate value of $1.21 million in AYLA stocks shares; and WELLINGTON MANAGEMENT GROUP LLP, currently with $1.11 million in AYLA stock with ownership of nearly -8.671% of the company’s market capitalization.

7 institutional holders increased their position in Ayala Pharmaceuticals Inc. [NASDAQ:AYLA] by around 158,040 shares. Additionally, 6 investors decreased positions by around 327,332 shares, while 3 investors held positions by with 4,298,522 shares. The mentioned changes placed institutional holdings at 4,783,894 shares, according to the latest SEC report filing. AYLA stock had 2 new institutional investments in for a total of 83,113 shares, while 1 institutional investors sold positions of 1,940 shares during the same period.